Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Eye (London, England)|July 30, 2021
Effectiveness and safety of ranibizumab in patients with central retinal vein occlusion: results from the real-world, global, LUMINOUS studyAndrew Lotery, Andreas Clemens, Raman Tuli, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 9, 2020
Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD DatabaseKonstantinos Kostikas, David Price, Florian S Gutzwiller, et al.
BMJ Open|January 29, 2014
Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomesArlene M Gallagher, Tjeerd P van Staa, Tarita Murray-Thomas, et al.
The European Respiratory Journal|July 30, 2016
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatmentFrederikus A Klok, Volker Hösel, Andreas Clemens, et al.
Thrombosis Research|July 31, 2012
Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysisBengt I Eriksson, Ola E Dahl, Martin Feuring, et al.
Thrombosis Research|June 19, 2012
Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trialsBengt I Eriksson, John J Smith, Joseph Caprini, et al.
The American Journal of Cardiology|August 19, 2015
Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial)Rangadham Nagarakanti, Lars Wallentin, Herbert Noack, et al.
Thrombosis and Haemostasis|August 18, 2012
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectivenessAnuraag R Kansal, Michael Sharma, Carole Bradley-Kennedy, et al.
Acta Ophthalmologica|September 19, 2022
Efficacy and safety of brolucizumab in age-related macular degeneration: A systematic review of real-world studiesCaroline R Baumal, Torben Lykke Sørensen, Helene Karcher, et al.
Thrombosis Journal|November 19, 2015
Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trialsBengt I Eriksson, Ola E Dahl, Nadia Rosencher, et al.
Pageof 9